Mclaren Northern Michigan

Mclaren Northern Michigan was paid $20.50M by Medicaid between Jan 2018 and Dec 2024, across 306 billing codes. Its largest line is 99283, emergency room visit (moderate) — 16% of everything it billed.

33Billing provider infoMCLAREN NORTHERN MICHIGAN
PETOSKEY, MI 49770

33aNPI1992812580assigned 08/23/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$20.50M

24GClaims756,730

24DCodes billed306

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Michigan

Rank by total paid#46 of 86

Median peer was paid$21.55M

This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	101,906	$2.76M
2019	127,941	$2.81M
2020	108,091	$2.60M
2021	120,414	$3.28M
2022	108,316	$3.06M
2023	105,602	$3.24M
2024incomplete	84,460	$2.75M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	16%	27,582	25,810	$3.37M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	13%	13,485	12,503	$2.57M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	12%	6,594	6,156	$2.38M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	5.7%	12,363	11,114	$1.16M
99282	Emergency department visit for the evaluation and management, low to moderate severity	5.4%	16,160	15,137	$1.10M
74177	Computed tomography, abdomen and pelvis; with contrast material	3.3%	4,969	4,780	$677K
45380	Colonoscopy, flexible; with biopsy, single or multiple	2.9%	1,183	1,172	$597K
95810	Polysomnography; sleep staging with 4 or more additional parameters	2.5%	1,124	1,117	$514K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	2.4%	24,443	6,858	$486K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	2.1%	2,151	2,121	$435K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	2.0%	1,212	1,208	$412K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.0%	4,604	3,733	$411K

294 more codes

96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.7%	3,567	$349K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.6%	2,128	$325K
70450	Computed tomography, head or brain; without contrast material	1.5%	3,581	$317K
96375	Therapeutic injection; each additional sequential IV push	1.2%	10,991	$256K
80061	Lipid panel	1.2%	8,998	$248K
71046	Radiologic examination, chest; 2 views	1.2%	7,092	$238K
96361	Intravenous infusion, hydration; each additional hour	1.2%	10,965	$236K
42820	Tonsillectomy and adenoidectomy; younger than age 12	1.1%	104	$234K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	948	$199K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	2,648	$198K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	4,881	$195K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	1,509	$187K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	8,340	$182K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	4,634	$172K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,495	$161K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	448	$157K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	3,093	$147K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	9,768	$134K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	5,772	$130K
71045	Radiologic examination, chest; single view	<1%	3,634	$125K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	242	$123K
G0378	Hospital observation service, per hour	<1%	3,511	$121K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	230	$95K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	186	$89K
97161		<1%	1,668	$81K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	2,564	$80K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	1,421	$75K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	674	$65K
71275	Computed tomographic angiography, chest, with contrast material	<1%	796	$61K
94060		<1%	490	$60K
S4005	Interim labor facility global (labor occurring but not resulting in delivery)	<1%	464	$50K
80053	Comprehensive metabolic panel	<1%	40,942	$44K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	336	$42K
93975		<1%	353	$38K
78815	Positron emission tomography (PET) for limited area imaging	<1%	48	$38K
84443	Thyroid stimulating hormone (TSH)	<1%	13,519	$38K
97162		<1%	771	$35K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	44,215	$35K
97014		<1%	4,137	$32K
94726		<1%	1,209	$31K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	5,130	$30K
76830	Ultrasound, transvaginal	<1%	543	$30K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	2,640	$29K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	2,594	$28K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	12,188	$28K
76536		<1%	516	$26K
96367		<1%	575	$25K
95800		<1%	300	$23K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,020	$23K
82947		<1%	1,124	$22K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	7,037	$21K
93017		<1%	948	$20K
72110		<1%	530	$18K
92526		<1%	429	$17K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	5,294	$17K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	1,339	$17K
76642		<1%	421	$16K
97035		<1%	2,875	$16K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	497	$16K
73630		<1%	1,788	$15K
36415	Collection of venous blood by venipuncture	<1%	47,757	$14K
71271		<1%	244	$14K
73564		<1%	1,062	$14K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,706	$14K
77063	Screening digital breast tomosynthesis, bilateral	<1%	1,118	$14K
87390		<1%	1,817	$14K
73030		<1%	1,271	$13K
97533		<1%	376	$13K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	229	$13K
72141		<1%	109	$13K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,656	$12K
73610		<1%	1,638	$12K
82607		<1%	3,848	$12K
82728		<1%	3,752	$11K
72125	Computed tomography, cervical spine; without contrast material	<1%	798	$11K
97535	Self-care/home management training, each 15 minutes	<1%	744	$11K
97116		<1%	969	$10K
86900		<1%	1,487	$10K
80055		<1%	538	$10K
74018		<1%	728	$9K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,781	$9K
73130		<1%	1,389	$9K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	767	$9K
86702		<1%	1,817	$8K
96415		<1%	201	$8K
87086	Culture, bacterial; quantitative colony count, urine	<1%	6,864	$8K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	830	$7K
82746		<1%	2,145	$7K
83880		<1%	2,299	$7K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,565	$7K
86803		<1%	1,525	$6K
83735		<1%	10,471	$6K
93971		<1%	120	$6K
88304		<1%	1,508	$6K
77336		<1%	89	$6K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	385	$6K
87081		<1%	4,374	$5K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,210	$5K
84439		<1%	3,143	$5K
73110		<1%	871	$5K
86701		<1%	1,827	$5K
87653		<1%	375	$5K
87522	Neg quan hep c or qual rna	<1%	325	$5K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	8,738	$5K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	85	$5K
87660		<1%	1,061	$5K
87480		<1%	1,061	$5K
70486		<1%	119	$5K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	128	$5K
80048	Basic metabolic panel (calcium, ionized)	<1%	7,591	$5K
83540		<1%	3,114	$4K
87510		<1%	1,044	$4K
74019		<1%	252	$4K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	39	$4K
85027		<1%	6,080	$4K
83550		<1%	1,970	$4K
71250		<1%	62	$3K
84702		<1%	1,381	$3K
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	<1%	12	$3K
72100		<1%	102	$3K
59025	Fetal non-stress test	<1%	30	$3K
73221		<1%	28	$3K
73502		<1%	260	$3K
87077		<1%	2,278	$3K
88342		<1%	329	$3K
87186		<1%	2,130	$3K
85610		<1%	5,445	$2K
86140		<1%	3,850	$2K
87070		<1%	1,616	$2K
84484		<1%	9,680	$2K
97165		<1%	57	$2K
86850		<1%	1,609	$2K
70491		<1%	14	$2K
86038		<1%	738	$2K
87902		<1%	30	$2K
80076		<1%	857	$1K
73140		<1%	217	$1K
82570		<1%	1,642	$1K
81001		<1%	10,089	$1K
87340		<1%	383	$1K
83516		<1%	373	$1K
84100		<1%	1,161	$1K
86706		<1%	339	$1K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	2,159	$1K
29125		<1%	208	$1K
82950		<1%	682	$1K
93296		<1%	57	$1K
86780		<1%	233	$990.19
85652		<1%	2,510	$967.36
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	596	$889.44
83690		<1%	6,082	$866.20
83615		<1%	856	$846.21
87205		<1%	1,465	$832.75
85730		<1%	2,604	$755.56
86777		<1%	131	$721.76
72050		<1%	13	$715.55
84550		<1%	637	$696.23
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	296	$679.92
82043		<1%	1,204	$679.09
84481		<1%	230	$671.52
93225		<1%	12	$647.90
82150		<1%	1,961	$637.44
81003		<1%	8,052	$605.59
73080		<1%	126	$557.13
84153		<1%	131	$531.54
82565		<1%	2,462	$492.97
73700		<1%	12	$455.35
77065	Tomosynthesis, mammo	<1%	13	$449.60
90686		<1%	38	$418.66
82948		<1%	4,769	$403.79
73562		<1%	31	$398.94
94010		<1%	118	$392.91
86787		<1%	81	$373.08
70496		<1%	13	$365.14
81025		<1%	9,300	$356.07
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,404	$349.60
83970		<1%	40	$306.29
86431		<1%	265	$292.60
87040		<1%	1,998	$289.95
87075		<1%	274	$286.01
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	25	$273.17
83001		<1%	64	$241.24
73090		<1%	12	$240.70
74022		<1%	29	$231.82
85379		<1%	2,023	$213.15
70498		<1%	14	$212.48
86901		<1%	1,782	$204.14
86704		<1%	51	$203.54
83874		<1%	2,815	$175.60
G0008	Administration of influenza virus vaccine	<1%	45	$168.00
82550		<1%	302	$163.23
82977		<1%	88	$138.74
84403		<1%	62	$129.63
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	11,762	$124.08
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	7,228	$115.00
88142		<1%	15	$113.88
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	71	$105.19
86738		<1%	512	$104.63
82553		<1%	2,833	$100.72
87430		<1%	1,707	$90.70
83605		<1%	4,423	$86.56
84450		<1%	68	$82.17
82784		<1%	27	$80.64
82670		<1%	16	$79.25
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	12,154	$69.72
84156		<1%	103	$68.77
82172		<1%	14	$66.25
84460		<1%	51	$63.15
71101		<1%	12	$60.49
12001		<1%	374	$58.33
82077		<1%	841	$47.63
J1170	Injection, hydromorphone, up to 4 mg	<1%	3,427	$46.24
83010		<1%	14	$43.84
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	988	$38.77
84425		<1%	14	$32.48
80143		<1%	474	$30.80
80179		<1%	469	$30.80
84132		<1%	101	$28.23
83721		<1%	13	$26.87
86769		<1%	12	$24.65
80178		<1%	17	$24.12
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,340	$23.00
J2704	Injection, propofol, 10 mg	<1%	7,370	$23.00
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,607	$23.00
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	7,141	$23.00
82248		<1%	18	$20.32
J2060	Injection, lorazepam, 2 mg	<1%	1,990	$19.00
84145		<1%	124	$17.93
82247		<1%	19	$17.50
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	337	$10.00
86308		<1%	56	$9.32
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	266	$9.24
85018		<1%	14	$6.87
J7030	Infusion, normal saline solution , 1000 cc	<1%	3,006	$2.58
J0780	Injection, prochlorperazine, up to 10 mg	0%	489	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	629	$0.00
94664		0%	1,415	$0.00
88313		0%	321	$0.00
84520		0%	16	$0.00
J2270	Injection, morphine sulfate, up to 10 mg	0%	1,908	$0.00
J1200	Injection, diphenhydramine hcl, up to 50 mg	0%	2,696	$0.00
90715		0%	505	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	310	$0.00
94729		0%	1,226	$0.00
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	0%	1,111	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	262	$0.00
99152		0%	399	$0.00
J7120	Ringers lactate infusion, up to 1000 cc	0%	1,110	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	49	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	128	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	96	$0.00
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	0%	216	$0.00
J1644	Injection, heparin sodium, per 1000 units	0%	236	$0.00
C9113	Injection, pantoprazole sodium, per vial	0%	80	$0.00
88312		0%	28	$0.00
93325		0%	68	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	27	$0.00
J1171	Injection, hydromorphone, 0.1 mg	0%	64	$0.00
J7510	Prednisolone oral, per 5 mg	0%	16	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	14	$0.00
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	0%	17	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	28	$0.00
Q9950	Injection, sulfur hexafluoride lipid microspheres, per ml	0%	14	$0.00
73590		0%	13	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	14	$0.00
J0696	Injection, ceftriaxone sodium, per 250 mg	0%	1,547	$0.00
96376		0%	2,717	$0.00
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	0%	1,133	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	282	$0.00
97010		0%	4,480	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	529	$0.00
C1769	Guide wire	0%	86	$0.00
G0283	Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care	0%	135	$0.00
72170		0%	13	$0.00
12002		0%	12	$0.00
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	0%	339	$0.00
J3490	Unclassified drugs	0%	3,602	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	42	$0.00
A9270	Non-covered item or service	0%	9,678	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	326	$0.00
A9585	Injection, gadobutrol, 0.1 ml	0%	497	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	637	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	269	$0.00
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	0%	126	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	209	$0.00
99153	Mod sedat endo service >5yrs	0%	112	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	14	$0.00
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	0%	90	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	79	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	45	$0.00
J3480	Injection, potassium chloride, per 2 meq	0%	19	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	12	$0.00
77417		0%	28	$0.00
93320		0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialPRUSAITIS, MICHAEL (CFO)